プロフィール詳細

プロジェクトを作成

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Abhilash D.に依頼

Israel

PhD Immuno-oncology Researcher | Tumor Microevironment and Metastasis Expert | EMBA-backed Strategic Insight for R&D

プロフィール概要

Scientist leader with 10+ years of translational cancer research experience combining deep scientific expertise with cross-functional project leadership, strategic decision-making, and global collaboration. Currently a Postdoctoral Research Fellow at Technion leading multi-centre projects in immunotherapy resistance, therapy-induced metastasis, and biomarker development. Proven record of delivering high-impact scientific outcomes, leading 4-6 concurrent translational projects, mentoring junior scientists, and managing cross-functional collaborations including a major partnership with a clinical research group in Germany. Core Competencies: Translational research, Oncology biomarker strategy, Immuno-oncology, Scientific leadership, Cross-functional collaboration, Project management, Data interpretation, Team training, Stakeholder communication

専門分野

• ☆ Molecular Biology
• ☆ Biomarkers
• ☆ Cancer Research
• ☆ Cancer Biology

サービス

• Writing

Writing Technical Writing

職務経験

Pos-doctoral Research Fellow

Technion – Israel Institute of Technology

2021 - 現在

学歴

PhD

Advanced Centre for Treatment Research and Education in Cancer

8月 2015 - 6月 2021

認定資格

• 認定資格の詳細は未入力です。

出版物

JOURNAL ARTICLE

Rotem Menachem, Igor Nudelman, Avital Vorontsova, Ido Livneh, Mor Sela, Madeleine Benguigui, Bar Manobla, Yael Shammai, Abhilash Deo, Chen Buxbaum, et al. (2025). Bone Marrow-Targeted Liposomes Loaded with Bortezomib Overcome Multiple Myeloma Resistance . ACS Nano.

C Buxbaum, A Deo, B Manobla, S Levin, S Ash, Y Shaked (2024). P16.07.A STUDYING NEUROBLASTOMA TUMOR MICROENVIRONMENT THROUGH A NOVEL PRE-CLINICAL MODEL . Neuro-Oncology.

Abhilash Deo, Jonathan P Sleeman, Yuval Shaked (2024). The role of host response to chemotherapy: resistance, metastasis and clinical implications . Clinical & Experimental Metastasis.

Madeleine Benguigui, Tim J. Cooper, Prajakta Kalkar, Sagie Schif-Zuck, Ruth Halaban, Antonella Bacchiocchi, Iris Kamer, Abhilash Deo, Bar Manobla, Rotem Menachem, et al. (2024). Interferon-stimulated neutrophils as a predictor of immunotherapy response . Cancer Cell.

Madeleine Benguigui, Avital Vorontsova, Michael Timaner, Sapir Levin, Jozafina Haj-Shomaly, Abhilash Deo, Rotem Menachem, Bar Manobla, Tim J. Cooper, Ziv Raviv, et al. (2022). Bv8 Blockade Sensitizes Anti-PD1 Therapy Resistant Tumors . Frontiers in Immunology.

Abhilash Nitin Deo, Rahul Thorat, Ajit Chandrakant Dhadve, Abhijit De, Bharat Rekhi, Pritha Ray (2022). IGF1R-α6 integrin-S100A4 network governs the organ-specific metastasis of chemoresistant epithelial ovarian cancer cells . Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.

Pritha Ray, Abhilash Deo, Souvik Mukherjee, Bharat Rekhi (2020). Subtype specific biomarkers associated with chemoresistance in epithelial ovarian cancer . Indian Journal of Pathology and Microbiology.

Pritha Ray, Abhilash Deo, Souvik Mukherjee, Bharat Rekhi (2020). Subtype specific biomarkers associated with chemoresistance in epithelial ovarian cancer . Indian Journal of Pathology and Microbiology.

Abhilash Deo, Smrita Chaudhury, Sadhana Kannan, Bharat Rekhi, Amita Maheshwari, Sudeep Gupta, Pritha Ray (2019). Igf1R Predicts Better Survival in High-Grade Serous Epithelial Ovarian Cancer Patients and Correlates with Hctr1 Levels . Biomarkers in Medicine.

Muskaan Belani, Abhilash Deo, Preeti Shah, Manish Banker, Pawan Singal, Sarita Gupta (2018). Differential insulin and steroidogenic signaling in insulin resistant and non-insulin resistant human luteinized granulosa cells—A study in PCOS patients . The Journal of Steroid Biochemistry and Molecular Biology.